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PVALUES DO NOT TELL THE WHOLE STORY
show that the measured effects might be due to chance, not that they are due to chmlce, The d~fferent results are still consistent with one another. If interferon treatment ac tually results in a 5% improvement in 3 year survival, the differences among the three study results could simply be due to random sampling variation. The problem with the p values is that they did not tell us how different the results could have been without generating a statistically significant result, s Some authors choose to address this issue by estimating the power of the study, but this is superfluous (Goodmml and Berlin offer an excellent discussion of the merits of confidence intervals over power calculationsT). In stead, the confidence intervals draw attention to the prob lem~because all three trials are small, the estimates of effect are imprecise. One appropriate interpretation would be that we do not have enough data to make an accurate determination of the effectiveness of interferon, However. all three trials are consistent with a small benefit.
The conceptual advantage of confidence intervals is also seen if we imagine that only the first study, by Mandelli et al., 1 is available (the first row in Table 1 ). If you are like me, the fact that this study is of borderline signifi cance (p ,04) will bother you. We know that we must draw the line somewhere, but it does not seem right that a small difference in results (say, a few more deaths in the interferon arm) should make a major difference in our recommendations. The confidence interval shows us why:
this barely significant study gives us an estimate that is not very precise (a difference between groups of 2% to 38% 
INTERPRETING CLINICAL TRIALS LIKE TEST RESULTS
Another way to look at a clinical trial is to consider it much as one would consider a laboratory test. theorem can be applied to clinical research, in The likelihood that a particular treatment is effective is related to the results of a study and to the probability that the treat ment would be effective based on prior information, When a treatment effect is found that seems unlikely, we may disbelieve it: Bayes' theorem tells us that the result is more likely an incorrect one (see Fig. 2 ), Thus. if we again look only at Mandellfs study in Table 1 , whether we recommend interferon treatment to our patient may appro priately depend not only on our interpretation of the confidence interval, but also on our previous beliefs, If we are well versed in the laboratory research on interferons and are convinced that they have an important therapeutic role. we may accept this clinical trial as confirmatory and encourage our patient to proceed with interferon treat ment. Conversely. if we have used interferon for years and have seen little more than side effects without clinical benefit, we may rightly discourage our patient and urge restraint until the value of interferon is confirmed, To be fair. of course, we should let our patient know the reasons for our prejudices.
The point here is that. as clinicians, we do not evaluate test results on patients in a vacuum: we consider all data. Why should we treat research results from a clinical 
INTERPRETING MULTIPLE COMPARISONS
A Bayesian approach can also resolve the problem of multiple comparisons, a controversial subject among statisticians, Let me first explain the problem, When many p values (or confidence intervals) are calculated, the probability that one or more significant differences will be found by chance alone increases, As, by definition, there is a 95% chance with each comparison that the p value will be >,05 when there is really no difference between the groups compared, the probability of two p values both being >.05 is 95% times 95%, or 90~
For three compari sons. all with p > .05, the probability is 86%. survival calculations. They looked at survival differences between treatment groups first for all patients, then for only those patients who responded to induction chemo therapy, mid finally for those who had only stable disease after induction. Only in the second group, those who re sponded to induction chemotherapy, was the survival dff ference significant, However, we have Just seen that the likelihood that at least one of the three comparisons would have a p value < .05, even without a treatment ef fect, is actually 14o/o! We have lost our 95% confidence that the survival difference is not due to chance alone.
How do we deal with this?
Some statisticians recommend making an adjustment in the significance level in this situation, but this approach increases the likelihood of missing true treat ment effects and lacks consistency, is, If, instead, we use Bayes" theorem to help determine the significance of re suits, we can more easily discriminate between fishing ex peditions and useful findings, In our example, we must decide how plausible it is that survival differences would show up only in the group of patients who responded to chemotherapy. If we accept the authors' implicit belief that this is plausible, the statistically significant result takes on greater importance: i.e., it is more likely a true positive (see Fig. 2 ). Alternatively. if we think the authors were only hunting for a positive result and there was no reason for subdividing the patient groups, we may interpret this result very cautiously indeed.
SUMMARY
Let us now return to the patient, Using confidence intervals instead ofp values allows us to tell him that inter feron treatment may not be very important, although the information we have is limited. We can discuss why his friend might have recommended interferon and what fac tops led us to agree or disagree. We need not make an ar bitrary decision. We can use our clinical knowledge, our intuition, and our understanding of our patient, together with the results of the clinical trials, to tailor our recom mendations to him, In conclusion:
, Remember that a difference that is not statistically sig nificmK is not the same as no difference, , Use confidence intervals, not p values, to interpret data. whenever possible. This avoids the problem of false-negative findings and simultaneously provides insight into the precision of results.
, Allow your clinical knowledge to help put research resuits into perspective. It is appropriate to interpret clinical trials in conjunction with other information.
